MAPTARGA Trademark

Trademark Overview

On Thursday, April 21, 2011, a trademark application was filed for MAPTARGA with the United States Patent and Trademark Office. The USPTO has given the MAPTARGA trademark a serial number of 85301364. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 19, 2021. This trademark is owned by Glaxo Group Limited. The MAPTARGA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardio...
maptarga

General Information

Serial Number85301364
Word MarkMAPTARGA
Filing DateThursday, April 21, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 19, 2021
Registration Number4718708
Registration DateTuesday, April 14, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddlesex UB060NN

Trademark Events

Event DateEvent Description
Friday, November 19, 2021CANCELLED SEC. 8 (6-YR)
Tuesday, April 14, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 14, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, November 6, 20141(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, November 5, 2014NOTICE OF ALLOWANCE CANCELLED
Wednesday, November 5, 2014TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, May 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 12, 2014EXTENSION 5 GRANTED
Wednesday, May 7, 2014EXTENSION 5 FILED
Wednesday, May 7, 2014TEAS EXTENSION RECEIVED
Saturday, October 26, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2013EXTENSION 4 GRANTED
Wednesday, October 23, 2013EXTENSION 4 FILED
Wednesday, October 23, 2013TEAS EXTENSION RECEIVED
Thursday, June 6, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 6, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 7, 2013EXTENSION 3 GRANTED
Thursday, May 2, 2013EXTENSION 3 FILED
Thursday, May 2, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 5, 2012EXTENSION 2 GRANTED
Thursday, November 1, 2012EXTENSION 2 FILED
Monday, November 5, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 1, 2012TEAS EXTENSION RECEIVED
Friday, April 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 4, 2012EXTENSION 1 GRANTED
Wednesday, April 4, 2012EXTENSION 1 FILED
Wednesday, April 4, 2012TEAS EXTENSION RECEIVED
Tuesday, November 8, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2011PUBLISHED FOR OPPOSITION
Tuesday, August 9, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 8, 2011ASSIGNED TO LIE
Tuesday, July 26, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 12, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 12, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 12, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 6, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 6, 2011LETTER OF SUSPENSION E-MAILED
Wednesday, July 6, 2011SUSPENSION LETTER WRITTEN
Thursday, June 30, 2011ASSIGNED TO EXAMINER
Monday, April 25, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 25, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

maptarga pharmaceutical treatment substances preparations disorders diseases alopecia cognitive obesity metabolic